Manassas, Va.
Covance Inc., a drug development services company, has selected a 300,000-sf facility in the Innovation Technology Park in Manassas, Va. as the site for its new pharmaceutical research and development laboratory. The Prince William county facility was originally constructed as an insulin manufacturing plant for Eli Lilly. Covance will expand the facility to a total of 410,000-sf at a cost of $175 million. Construction is slated for completion by January of 2011 with occupancy expected by the end of that year. Covance is headquartered in Princeton, N.J.
